spacer
home > ebr > summer 2002 > effective gene transfer in neurobiology
PUBLICATIONS
European Biopharmaceutical Review

Effective Gene Transfer in Neurobiology

The potential of gene therapy is now being realised, with therapeutic success in single gene inherited immunodeficiency disorders, and positive clinical progress in a number of other fields including cancer. Gene therapy is also showing great potential in the treatment of nerve injuries and neurodegenerative disorders, as solutions to some major challenges are found. The most fundamental challenge has been to achieve safe and efficient delivery of genes into the right cells in vivo. This article reviews the vectors available for gene therapy in neurobiological applications and examines potential gene therapy approaches for neurodegenerative disease and nerve regeneration.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Professor Alan Kingsman, Chief Executive Officer and Co-Founder of Oxford BioMedica plc, is an internationally-recognised authority on gene expression and retrovirus research and has over 20 years' experience in this field.
spacer
Professor Alan Kingsman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CRO and Sponsor Quality Award Finalists Announced by ACRP, The Avoca Group

Washington, DC – The Association of Clinical Research Professionals (ACRP) and The Avoca Group will jointly recognize leading Sponsors and CROs at the ACRP Awards & Recognition Ceremony on Friday, May 1, during the ACRP 2020 annual conference in Seattle, Washington.
More info >>

White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement